Home > National Drug Code (NDC) > Terazosin Hydrochloride

Terazosin Hydrochloride - 55154-1385-0 - (Terazosin Hydrochloride)

Alphabetical Index


Drug Information of Terazosin Hydrochloride

Product NDC: 55154-1385
Proprietary Name: Terazosin Hydrochloride
Non Proprietary Name: Terazosin Hydrochloride
Active Ingredient(s): 1    mg/1 & nbsp;   Terazosin Hydrochloride
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of Terazosin Hydrochloride

Product NDC: 55154-1385
Labeler Name: Cardinal Health
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA074823
Marketing Category: ANDA
Start Marketing Date: 20091102

Package Information of Terazosin Hydrochloride

Package NDC: 55154-1385-0
Package Description: 10 BLISTER PACK in 1 BAG (55154-1385-0) > 1 CAPSULE in 1 BLISTER PACK

NDC Information of Terazosin Hydrochloride

NDC Code 55154-1385-0
Proprietary Name Terazosin Hydrochloride
Package Description 10 BLISTER PACK in 1 BAG (55154-1385-0) > 1 CAPSULE in 1 BLISTER PACK
Product NDC 55154-1385
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Terazosin Hydrochloride
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 20091102
Marketing Category Name ANDA
Labeler Name Cardinal Health
Substance Name TERAZOSIN HYDROCHLORIDE ANHYDROUS
Strength Number 1
Strength Unit mg/1
Pharmaceutical Classes Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]

Complete Information of Terazosin Hydrochloride


General Information